CD79a (B Lymphoid Cell Marker)

image not found

NABL Cap Accredited 
The Orange Healthcare CD79a (B Lymphoid Cell Marker) Test is a specialised diagnostic investigation used to detect CD79a, a protein associated with the B-cell antigen receptor complex and expressed during various stages of B-lymphocyte development. CD79a plays an important role in B-cell activation, signalling, and immune responses. The Orange Healthcare CD79a (B Lymphoid Cell Marker) Test helps identify B-cell populations and supports the diagnosis and classification of B-cell leukaemias, lymphomas, and other lymphoproliferative disorders. CD79a expression is particularly useful in identifying B-cell lineage in certain immature or abnormal cell populations. Results should be interpreted alongside other immunophenotypic markers, tissue morphology, blood counts, and clinical findings.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 3,750.00 Rs. 4,875.00

23% OFF

Sample Type: Blood

Fasting Not Required


Booking Procedure:
  1. Select your preferred Orange Health test or package on BookMyTest and complete your booking with your details.
  2. Pick a convenient time slot. A trained eMedic will be assigned and can reach you within 60 minutes of booking or at your scheduled time.
  3. At your selected time, a trained eMedic will visit your doorstep for safe and hygienic sample collection using a painless single-prick method. Samples are securely stored and transported to certified labs for processing.
  4. Doctor-verified reports are shared via WhatsApp, email, and the Orange Health app. You can also access them anytime from your registered account.

Frequently Asked Questions (FAQ's):

1. What is the Orange Healthcare CD79a (B Lymphoid Cell Marker) Test?
It is a specialised laboratory test used to detect CD79a protein expression in B lymphocytes, helping identify B-cell lineage and characterise certain haematological disorders.

2. Why is the CD79a (B Lymphoid Cell Marker) Test performed?
The test is performed to support the diagnosis and classification of B-cell acute lymphoblastic leukaemia, B-cell lymphomas, and other lymphoproliferative disorders. It is commonly included in immunophenotyping panels to establish B-cell differentiation.

3. What does a positive CD79a result indicate?
A positive result indicates CD79a expression in the examined cells and generally supports B-cell lineage. CD79a may be expressed in normal B lymphocytes and several B-cell malignancies. However, positivity alone does not confirm cancer or establish a specific diagnosis.

4. What does a negative CD79a result indicate?
A negative result indicates that CD79a expression was not detected in the examined cell population. This may help distinguish certain non-B-cell populations from B-cell disorders. However, some B-cell malignancies may show reduced or absent CD79a expression, so additional markers are necessary.

5. Is fasting required for the Orange Healthcare CD79a (B Lymphoid Cell Marker) Test?
Fasting is generally not required. Patients can usually eat and drink normally before blood sample collection. If a bone marrow examination, tissue biopsy, or procedure involving sedation is planned, specific preparation instructions may apply.

6. What sample is required for the CD79a (B Lymphoid Cell Marker) Test?
The required specimen depends on the clinical indication and testing method. Tissue biopsy or bone marrow biopsy specimens are commonly examined using immunohistochemistry, while peripheral blood, bone marrow aspirates, or fresh tissue samples may be analysed using flow cytometry to assess CD79a expression.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab